Rapid Growth Ahead: NGS Market Set to Hit USD 50 Billion by 2032
The global Next-Generation Sequencing (NGS) market Size, valued at USD 8.3 billion in 2023, is on a transformative path, expected to surge to USD 50.0 billion by 2032, according to a comprehensive market analysis. This unprecedented growth reflects a compound annual growth rate (CAGR) of 22.0% during the forecast period from 2024 to 2032.
NGS has revolutionized the field of genomics and molecular biology by allowing rapid sequencing of entire genomes at a fraction of the cost and time of traditional methods. Its applications have expanded far beyond basic research to encompass personalized medicine, oncology, infectious diseases, reproductive health, and agricultural genomics.
Get Free Sample Report on Next Generation Sequencing Market
https://www.snsinsider.com/sample-request/3720
Market Overview
Next-generation sequencing, also known as high-throughput sequencing, has become a cornerstone of precision medicine and genetic diagnostics. Continuous innovation, plummeting sequencing costs, and rising demand for advanced genomic analysis are the major driving forces behind the market’s explosive expansion.
The market’s trajectory is further supported by growing investments in genomic research by public and private sectors, alongside increasing collaborations among biotechnology companies and academic institutions.
Market Drivers
1. Widespread Adoption in Clinical Applications
NGS is increasingly used in clinical diagnostics, particularly in oncology for identifying mutations and guiding targeted therapies. Liquid biopsy, a non-invasive cancer detection method based on NGS, is gaining momentum, driving market growth.
2. Rising Demand for Precision Medicine
As healthcare shifts towards personalized treatment regimens, NGS plays a pivotal role in delivering genetic insights that shape tailored therapeutics. The push for individualized medicine across cancer, cardiovascular, and rare diseases significantly boosts demand.
3. Decreasing Cost of Sequencing
The cost of sequencing a human genome has plummeted from nearly USD 100 million to under USD 1,000, thanks to technological advancements. This affordability is opening new avenues for research, diagnostics, and consumer genomics.
4. Technological Advancements
Continuous improvements in NGS platforms, bioinformatics tools, and data analytics are making sequencing faster, more accurate, and scalable. Third-generation sequencing technologies are expanding possibilities even further.
5. Increased Genomic Research Funding
Government initiatives such as the Precision Medicine Initiative (USA) and Genomics England (UK) have significantly increased funding for genomic research, supporting the expansion of sequencing services worldwide.
Key Market Applications
➤ Oncology
NGS is transforming cancer research and care. Tumor profiling, mutation detection, and treatment resistance monitoring are key oncology applications fueling the NGS market.
➤ Infectious Disease Diagnosis
NGS enables pathogen identification, viral genome surveillance, and antibiotic resistance tracking, playing a crucial role during outbreaks such as COVID-19.
➤ Reproductive Health
Applications include non-invasive prenatal testing (NIPT), carrier screening, and embryo selection in IVF, with growing demand from both healthcare providers and patients.
➤ Agricultural Genomics
NGS aids crop improvement, animal breeding, and food safety testing, driving adoption in agricultural biotechnology.
➤ Forensics and Anthropology
NGS supports DNA profiling, ancestry testing, and ancient DNA sequencing, expanding the scope of law enforcement and academic studies.
Key Market Segments:
By Product
- Consumables
- Platforms
By Technology
- WGS
- Whole Exome Sequencing
- Targeted Sequencing & Resequencing
By Workflow
- Pre-Sequencing
- Sequencing
- NGS Data Analysis
By Application
- Oncology
- Clinical Investigation
- Reproductive Health
- HLA Typing/Immune System Monitoring
- Metagenomics
- Epidemiology & Drug Development
- Agrigenomics & Forensics
- Consumer Genomics
By End User
- Academic Research
- Clinical Research, Hospitals & Clinics
- Pharma & Biotech Entities
- Other Users
Key Players in the Next-generation sequencing Market
· Illumina (NovaSeq Series, MiSeq, NextSeq Series)
· F. Hoffman-La Roche Ltd. (GeneReader, NimbleGen)
· QIAGEN (GeneReader NGS System, QIAseq)
· Thermo Fisher Scientific, Inc. (Ion Proton System, Ion S5 System, Applied Biosystems GeneMapper Software)
· Bio-Rad Laboratories, Inc. (ddPCR (Droplet Digital PCR))
· Oxford Nanopore Technologies (MinION, GridION, PromethION)
· PierianDx (PierianDx Platform)
· Genomatix GmbH (Genomatix Suite)
· DNASTAR, Inc. (Lasergene Genomics Suite)
· Perkin Elmer, Inc. (BioQule NGS System)
· Eurofins GATC Biotech GmbH (GATC Biotech NGS Services)
· BGI (BGISEQ Series)
· PacBio (Sequel II System)
· Agilent Technologies
Future Outlook
The Next-Generation Sequencing market is poised for remarkable transformation as sequencing becomes a foundational technology across industries. The convergence of AI, bioinformatics, cloud computing, and personalized healthcare will redefine genomic medicine.
Future growth will be characterized by:
- Miniaturization and portability of sequencing devices
- Increased integration of NGS in primary care
- Emergence of direct-to-consumer (DTC) genomics
- Enhanced interoperability between sequencing and electronic health records (EHRs)
Conclusion
The Next-Generation Sequencing market is on a steep upward curve, backed by its expanding role in precision medicine, clinical diagnostics, and biotech innovation. With a projected valuation of USD 50.0 billion by 2032, NGS is set to revolutionize healthcare, agriculture, and research at an unprecedented pace.
Stakeholders across the value chain—from researchers and clinicians to biotech firms and policymakers—must gear up to harness the full potential of this transformative technology.
About US
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK).
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Игры
- Gardening
- Health
- Главная
- Literature
- Music
- Networking
- Другое
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness
- IT, Cloud, Software and Technology
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian